Brian Blackman

Brian Blackman has served as our Chief Financial Officer since July 2016. Mr. Blackman has over 15 years of experience in the biotech industry in finance and business development and has previously served as Vice President, Finance and Administration for VLST Corporation and served as Director, Business Operations for BN ImmunoTherapeutics, Inc., a subsidiary of Bavarian Nordic, Inc. Prior to that, Mr. Blackman served as Senior Manager, Business Development for Dendreon Corporation from 2005 to 2008, joining the company in 2004 as Senior Area Finance Manager. His career in financial management has also included work at Penton Media, Inc. as senior financial analyst and Amgen, Inc. serving as financial analyst for Amgen Colorado. Mr. Blackman received a B.S. in Finance from the University of Colorado at Boulder and an M.B.A. from London Business School, UK.